Upcoming events

Time

Topic/Event

Speaker

8:00am

Registration Opens

9.00 – 9.10

Opening remarks and meeting objectives

Bijan Modarai

King’s Health Partners, London, UK

9.10 – 10.45

Session 1: When should we intervene in Aortic Dissection?

Timing, surveillance and identifying the patient at risk  

Chair: Colin Bicknell

Discussants: Narayan Karunanithy and Firas Mussa

9.10 – 9.20

The Role of the interdisciplinary "Aortic Team" in optimising the emergency transfer of patients and its impact on outcome

Marcus Brooks

North Bristol NHS Trust, UK

9.20 – 9.30

Imaging surveillance after Type B dissection: How often, what to look for, and what we may be missing

Federica Catapano

Humanitas Research Hospital, Milan, Italy

9.30 – 9.40

Contemporary analysis techniques for multimodal data and how it can inform the management of type B aortic dissection

Kak Khee Yeung

University of Amsterdam, Netherlands

9.40 – 9.50

Guidelines vs reality: Where evidence fails in Type B aortic dissection

Anders Wanhainen

University of Uppsala, Sweden

9.50 - 10.05

Perspectives on survivorship and surveillance

Martin Hilton

Patient representative,  Aortic Dissection Charitable Trust &

Tara Mastracci

Barts Health, London, UK

10.05 – 10.30

Discussion

10.30 – 10.45

The Sir Harold Ellis Distinguished Lecture

Introduction: Bijan Modarai

Endovascular reconstruction of the dissected ascending aorta and arch: Defining strategy in the era of fenestrated and branched repair and what comes next

Vote of thanks: Tara Mastracci

Stéphan Haulon

Hopital Marie Lannelongue, Paris, France

10.45 – 11.15

COFFEE

11.15 – 12.45

Session 2: Choosing the right strategy: Open, endovascular or hybrid?

Defining the optimal treatment approach for complex anatomy

Chair: Tim Resch

Discussants: Anders Wanhainen and Nimesh Desai

11.15 – 11.25

From open to hybrid to total endovascular: Navigating the transition in the treatment of the dissected aortic arch

Nimesh Desai

University of Pennsylvania, USA

11.25 – 11.35

Do we need a more effective solution for chronic false lumen sac management?

Gustavo Oderich

Baylor Medicine Centre for Aortic Surgery, USA

11.35 – 12.15

Strategy & Future Scoping Roundtable

1.     Remote Monitoring in Aortic Dissection

2.     Is remodelling for chronic dissection important and if so how can we achieve it?

3.    Functional and haemodynamic assessment of the dissected aorta, with potential AI integration

4. Endovascular technologies in connective tissue disease

Lead discussant:

Tim Resch

University of Copenhagen, Denmark

Expert panel:

Anders Wanhainen

Stéphan Haulon

Nimesh Desai

Eric Roselli

Tara Mastracci

Kak Khee Yeung

12.15 – 12.35

INTEGRATED AORTIC TEAM DEBATE : 

Convenors: Tara Mastracci/Barend Mees

One Aorta. Four Experts. One Decision?

Each expert presents, defends and critiques their preferred open or endovascular strategy for the same complex aortic dissection.

Nimesh Desai

University of Pennsylvania, USA &

Eric Roselli

Cleveland Clinic, USA

Stéphan Haulon

Hopital Marie Lannelongue, Paris, France &

Gustavo Oderich

Baylor Medicine Centre for Aortic Surgery, USA

12.35 – 12.45

Cook Medical Guest Lecture

12.45 – 1.35

LUNCH

1.35 – 3.20

Session 3: Technical reality: Solving the hard problems in dissection:

Malperfusion, access issues, failure and decision making

Chair: Germano Melissano

Discussants: Kak Khee Yeung and Michael Sabetai

1.35 – 1.50

Off-the-shelf endovascular solutions will replace custom and physician-modified devices in aortic dissection

For: Tim Resch

University of Copenhagen, Denmark

Against: Gustavo Oderich

Baylor Medicine Centre for Aortic Surgery, USA

1.50 – 2.00

Malperfusion in Type A aortic dissection: When, how and what to fix first

Eric Roselli

Cleveland Clinic, USA

2.00 – 2.10

The hostile access: Navigating true lumen Collapse, iliac malperfusion, and the inaccessible branch vessel

Barend Mees

Maastricht Heart+Vascular Center, Maastricht, Netherlands

2.10 – 2.20

Complications of TEVAR in dissection: Risk factors, prevention, recognition and bailout strategies

Stephen Cheng

University of Hong Kong

2.20 – 2.40

Discussion

2.40 – 3.10

INTERACTIVE MDT SIMULATION

Cases for discussion:

Becky Sandford

Mohamed Abdelhalim

Expert panel:

Judith Partridge

Panos Gkoutzios

Eric Roselli

Colin Bicknell

Michael Sabetai

Stephen Cheng

3.10 – 3.20

GORE Guest Lecture

Optimising Aortic Arch Treatment: Clinical Experience with the GORE® TAG® Thoracic Branch Endoprosthesis

David Murray

Manchester Vascular Centre, Manchester Royal Infirmary, UK

3.20 – 3.50

TEA

3.50 – 5.30

Session 4: Evidence, Trials and the limits of what we know: Data, uncertainty and the need for a new framework

Chair: Kevin Mani

Discussants: Sandeep Bahia and Stephen Cheng

3.50 – 4.10

Global roundtable on evidence for managing uncomplicated type B dissection :

3 minute update on uncomplicated TBAD trials

Discussion points:

1. Medical optimisation, how is this being achieved in practice in the trials?

2. Does device choice and timing of intervention really change outcomes?

3. What are we learning from the patients not included in the trials? Data from screening

4. How generalisable are these trials – Management of dissections and centers of expertise

Moderator:

Kevin Mani

Uppsala University, Sweden

Panel:

Firas Mussa

UTHealth Houston McGovern Medical School, USA

Colin Bicknell

Imperial College London, UK

Jacob Budtz-Lilly

Aarhus University, Denmark

4.10 – 4.25

IMH is not a separate disease, it should be treated the same as dissection

For: Firas Mussa

UTHealth Houston McGovern Medical School, USA

Against: Jacob Budtz-Lilly,

Aarhus University, Denmark

4.25 – 4.40

When treatment creates the next problem:

1. Distal stent-induced new entry (dSINE)

2. Extensive aortic coverage and altering stiffness

Kak Khee Yeung

University of Amsterdam, Netherlands

Anders Wanhainen

University of Uppsala, Sweden

4.40 – 4.50

The STABILISE registry: What have we learnt?

Germano Melissano,

"Vita-Salute” San Raffaele, University of Milan, Italy

4.50 – 5.00

Trends in epidemiology and outcome of aortic dissections – a national population-based study

Kevin Mani

Uppsala University, Sweden

5.00 – 5.25

Discussion

5.30

Closing remarks

Bijan Modarai

King’s Health Partners, London, UK